Munich, January 8th, 2025 – athagoras, a leading specialized life science consulting group, today announced the acquisition of Quantify Research, a Nordic-headquartered specialist in real-world evidence (RWE) and market access. The acquisition expands athagoras’ global capabilities, adding a leading presence in the Nordic countries and strategic reach into Asia-Pacific. Founded in 2011, Quantify Research serves nineteen of the top twenty global pharmaceutical companies through three core practice areas: Real-World Evidence and Analytics (RWEA), Modelling, Access & Strategy (MAS), and Evidence Review & Synthesis (ERS). The company provides end-to-end scientific services, leveraging Nordic real-world data covering over 150 million patient-years. Internationally recognised for its high quality, this data is increasingly utilised by payers and regulators in both the EU and U.S.
Strategic Rationale
The acquisition combines Quantify’s Nordic market leadership with athagoras’ strategy, creating a stronger platform to serve clients worldwide. In particular, the U.S. market’s demand for high-quality RWE and value demonstration continues to grow. athagoras will leverage its expanded capabilities to drive innovation and value across its portfolio.
Dr. Roman-Marcus Rittweger, CEO of athagoras, stated: “The acquisition of Quantify Research marks a significant step in our strategy to build a leading global Life Sciences consulting group. Quantify’s expertise in real-world evidence and market access complements our existing capabilities, enhancing our ability to support the Life Science industry and navigate the complex access landscape. We welcome the Quantify team to the athagoras family as we work together to shape the future of market access.”
“This partnership accelerates our international expansion and strengthens our ability to deliver comprehensive real-world evidence and market access solutions to clients,” said Dr. Kirk Geale, CEO of Quantify Research. “By joining forces with athagoras, we can leverage our unique Nordic data assets and market access expertise across a global platform, creating new opportunities for Life Sciences companies worldwide and continuing our mission to enable patient-centric healthcare.”
Future Outlook
athagoras will drive growth and innovation by expanding the scope of Quantify’s unique evidence solutions and creating synergies across its current and future portfolio companies. This acquisition strengthens athagoras’ progress towards becoming the European leader in life science consulting, offering unparalleled expertise and data-driven insights to Life Sciences companies worldwide. The expanded platform is well positioned for future growth and the delivery of innovative solutions that drive value for clients.
